by Mihnea Flavian IUGA | January 18, 2024
IND 15-1 15 min The Paradigm Shift in Relaxivity and Stability with Elucirem Jean-Sebastien Raynaud, Roissy CdG Cedex / France Innovative Characteristics of the new macrocyclic high-relaxivity low-gadolinium-dose GBCA IND 15-2 15 min Elucirem Clinical Cases CNS Laurie...
by Mihnea Flavian IUGA | January 18, 2024
During this symposium you will learn about imaging’s pivotal role in advanced cancer therapies! Specifically, we will explore innovations in early lung cancer detection and imaging in prostate cancer management, that will help guide personalized theranostics for...
by editor | January 18, 2024
Over 90% of HCC cases occur in the setting of chronic liver disease. The incidence of MASLD (metabolic dysfunction–associated fatty liver disease)-related HCC is projected to increase dramatically by 2030. Therefore, healthcare providers seek ways to better stratify...
by editor | January 18, 2024
The European breast cancer screening program has been in place for more than 20 years and has largely followed the same screening method: 2D FFDM with two projections every two years for nearly all women in a certain age group. Over the years, more differentiated,...
by Mihnea Flavian IUGA | January 18, 2024
During this symposium you will learn about Amyloid Related Imaging Abnormalities (ARIA) management and the evolving role of PET biomarkers in Alzheimer’s treatment . You will also gain insights into current amyloid therapies and cutting-edge imaging...
Recent Comments